Statistics for IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System
Total visits
views | |
---|---|
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System | 150 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
nihms-1512381.pdf | 150 |
java.util.UUID:a15cceb4-45c5-4c20-be6f-d0d5248ec9aa | 54 |
java.util.UUID:de2c6254-cce5-4f91-bebb-143da2f90275 | 21 |
java.util.UUID:e56c7258-626a-4fe0-8f09-056af4eab8c4 | 6 |
Top country views
views | |
---|---|
United States | 118 |
China | 5 |
Germany | 4 |
Canada | 2 |
Ukraine | 2 |
Vietnam | 2 |
United Kingdom | 1 |
Malaysia | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 49 |
Fairfield | 15 |
Houston | 10 |
Cambridge | 8 |
Jacksonville | 5 |
Shenzhen | 4 |
Ann Arbor | 3 |
Kiez | 3 |
Dong Ket | 2 |
Fontana | 2 |
Kiev | 2 |
Midland | 2 |
San Francisco | 2 |
Toronto | 2 |
Baltimore | 1 |
Chicago | 1 |
Falls Church | 1 |
Gunzenhausen | 1 |
Kansas City | 1 |
Mountain View | 1 |
Saint Petersburg | 1 |
Seremban | 1 |